Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Zeba Jahangir

Department of Medicine, University of Washington, Seattle, Albania
Publications

The Future of Immune Checkpoint Inhibitors in Cancer Treatment: Combining Immunotherapy with Targeted Therapies

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing the immune system to target and destroy tumor cells. Despite their significant success in cancers such as melanoma, non-small cell lung cancer, and renal cell carcinoma, many patients do not respond or develop resistance to these therapies. The combination of ICI... Read More»

Zeba Jahangir

: Immunol Curr Res 2024

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top